Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses

Avian Diseases

Volumn 55, Issue 2, 2011, Pages 263-272

  Gimeno, Isabel M ^a   Cortes, Aneg L ^a   Montiel, Enrique R ^b   Lemiere, Stephane ^b   Pandiri, Arun K R ^a,c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

Author keywords

control; dilution; Marek's disease; vaccines

Indexed keywords

MAREK DISEASE VACCINE; VIRUS DNA;

ANIMAL; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; IMMUNOLOGY; MALE; MARDIVIRUS; MAREK DISEASE; PATHOGENICITY; VIRULENCE;

ANIMALS; BODY WEIGHT; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; MALE; MARDIVIRUS; MAREK DISEASE; MAREK DISEASE VACCINES; VIRULENCE;

GALLID HERPESVIRUS 2; GALLUS GALLUS; MELEAGRID HERPESVIRUS 1;

EID: 79959287951     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9579-101510-Reg.1     Document Type: Article

References (43)

1. Baigent, S. J., L. P. Smith, R. J. Currie, and V. K. Nair. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathol. 36:467-474. 2007. (Pubitemid 350125609)
2. Basarab, O., and T. Hall. Comparisons of cell-free and cell-associated Marek's disease vaccines in maternally immune chicks. Vet. Rec. 99:4-6. 1976.
3. Biggs, P. M., A. E. Churchill, D. G. Rootes, and R. C. Chubb. The etiology of Marek's disease-an oncogenic herpes-type virus. Perspect. Virol. 6:211-237. 1968.
4. Biggs, P. M., and L. N. Payne. Transmission experiments with Marek's disease (fowl paralysis). Vet. Rec. 75:177-179. 1963.
5. Biggs, P. M., and L. N. Payne. Studies on Marek's disease. I. Experimental transmission. J. Natl. Cancer Inst. 39:267-280. 1967.
6. Calnek, B. W., R. W. Harris, C. Buscaglia, K. A. Schat, and B. Lucio. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis. 42:124-132. 1998. (Pubitemid 28159175)
7. Churchill, A. E. Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease. I. Studies in cell culture. J. Natl. Cancer Inst. 41:939-950. 1968.
8. Churchill, A. E., L. N. Payne, and R. C. Chubb. Immunization against Marek's disease using a live attenuated virus. Nature 221:744-747. 1969.
9. Colwell, W. M., D. G. Simmons, J. R. Harris, T. G. Fulp, J. H. Carrozza, and T. A. Maag. Influence of some physical factors on survival of Marek's disease vaccine virus. Avian Dis. 19:781-790. 1975.
10. Cortes, A. L., E. R. Montiel, and I. M. Gimeno. Validation of Marek's disease diagnosis and monitoring of Marek's disease vaccines from samples collected in FTA cards. Avian Dis. 53:510-516. 2009.
11. Cortes, A. L., E. R. Montiel, S. Lemiere, and I. M. Gimeno. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time-PCR. Avian Dis. 55:302-310. 2011.
12. de Boer, G. F., F. W. Orthel, M. Krasselt, H. L. Oei, W. J. Pereboom, and L. G. Barendregt. Comparative 50% protective dose assays (PD 50) of Marek's disease virus strain CVI988. J. Biol. Stand. 9:15-22. 1981. (Pubitemid 11187207)
13. Eidson, C. S., R. K. Page, and S. H. Kleven. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus. Avian Dis. 22:583-597. 1978.
14. Eidson, C. S., R. K. Page, and S. H. Kleven. In vivo and in vitro studies on the effect of gentamicin sulfate on the efficacy of the turkey herpesvirus vaccine. Poult. Sci. 57:1519-1525. 1978.
15. Fabricant, C. G., J. Fabricant, C. R. Minick, and M. M. Litrenta. Herpesvirus-induced atherosclerosis. In: Viruses in naturally occurring cancers. M. Essex, G. Todaro, and H. Z. Hausen, eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. pp. 1251-1258. 1980.
16. Gimeno, I. M. Marek's disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26(Suppl. 3):C31-C41. 2008. (Pubitemid 351899088)
17. Gimeno, I. M., A. L. Cortes, and R. F. Silva. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors. Avian Dis. 52:203-208. 2008. (Pubitemid 351883732)
18. Gimeno, I. M., R. L. Witter, H. D. Hunt, L. F. Lee, S. M. Reddy, and U. Neumann. Marek's disease virus infection in the brain: virus replication, cellular infiltration and major histocompatibility complex antigen expression. Vet. Pathol. 38:491-503. 2001. (Pubitemid 33617065)
19. Gimeno, I. M., R. L. Witter, and W. M. Reed. Four distinct neurologic syndromes in Marek's disease: effect of viral strain and pathotype. Avian Dis. 43:721-737. 1999. (Pubitemid 30001039)
20. Halvorson, D. A., and D. O. Mitchell. Loss of cell-associated Marek's disease vaccine titer during thawing, reconstitution and use. Avian Dis. 23:848-853. 1979.
21. Hunt, H. D., B. Lupiani, M. M. Miller, I. M. Gimeno, L. F. Lee, and M. S. Parcells. Marek's disease virus down regulates surface expression of MHV (B complex) class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology 282:198-205. 2001. (Pubitemid 32881787)
22. Islam, A. F., B. Harrison, B. F. Cheetham, T. J. Mahony, P. L. Young, and S. W. Walkden-Brown. Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction. J. Virol. Methods 119:103-113. 2004. (Pubitemid 38670401)
23. Islam, A. F., C. W. Wong, S. W. Walkden-Brown, I. G. Colditz, K. E. Arzey, and P. J. Groves. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge. Avian Pathol. 31:449-461. 2002. (Pubitemid 35224659)
24. Jones, D., L. F. Lee, J. L. Liu, H. J. Kung, and J. K. Tillotson. Marek disease virus encodes a basic-Leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. U. S. A. 89:4042-4046. 1992.
25. Kuhnlein, U., J. L. Spencer, M. Chan, D. Praslickova, K. Linher, A. Kulenkamp, and G. Ansah. Relationship between Marek's disease and the time course of viral genome proliferation in feather tips. Avian Dis. 50:173-178. 2006. (Pubitemid 44077075)
26. Landman, W. J., and S. B. Verschuren. Titration of Marek's disease cell-associated vaccine virus (CVI 988) of reconstituted vaccine and vaccine ampoules from Dutch hatcheries. Avian Dis. 47:1458-1465. 2003. (Pubitemid 37538174)
27. Otaki, Y., T. Nunoya, M. Tajima, S. Kato, and Y. Nomura. Depression of vaccinal immunity to Marek's disease by infection with chicken anaemia agent. Avian Pathol. 17:333-347. 1988.
28. Patrascu, I. V., B. W. Calnek, and M. W. Smith. Vaccination with lyophilized turkey herpesvirus (HVT) minimum infective and protective doses. Avian Dis. 16:86-93. 1972.
29. Purchase, H. G., W. Okazaki, and B. R. Burmester. The minimum protective dose of the herpesvirus turkeys vaccine against Marek's disease. Vet. Rec. 91:79-84. 1972.
30. Rosenberger, J. K. Reovirus interference with Marek's disease vaccination. In: Proc. Western Poultry Disease Conference, Davis, CA. pp. 50-51. 1983.
31. Schat, K. A., and B. W. Calnek. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082. 1978. (Pubitemid 8335952)
32. Schat, K. A., and V. K. Nair. Marek's disease. In: Diseases of poultry, 12th ed. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. Blackwell Publishing Professionals, Ames, IA. pp. 449-514. 2008.
33. Schat, K. A., and M. A. Skinner. Avian immunosupressive diseases and immune evasion. In: Avian immunology, 1st ed. F. Davison, B. Kaspers, and K. A. Schat, eds. Elsevier, Oxford, UK. pp. 289-298. 2008.
34. Sevoian, M., D. M. Chamberlain, and F. T. Counter. Avian lymphomatosis. I. Experimental reproduction of the neural and visceral forms. Vet. Med. 57:500-501. 1962.
35. Sharma, J. M. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine. Avian Dis. 28:629-640. 1984.
36. Shek, W. R., B. W. Calnek, K. A. Schat, and C. L. H. Chen. Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J. Natl. Cancer Inst. 70:485-491. 1983. (Pubitemid 13117196)
37. U.S. Department of Agriculture, Animal and Plant Health Inspection Service. Code of Federal Regulations. Title 9, Chapter I, part 113-330. Office of the Federal Register, Washington, DC. 2009.
38. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163. 1997. (Pubitemid 27153252)
39. Witter, R. L., and B. R. Burmester. Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines. Avian Pathol. 8:145-156. 1979.
40. Witter, R. L., and K. S. Kreager. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease. Avian Dis. 48:768-782. 2004. (Pubitemid 40059874)
41. Witter, R. L., L. F. Lee, L. D. Bacon, and E. J. Smith. Depression of vaccinal immunity to Marek's disease by infection with reticuloendotheliosis virus. Infect. Immun. 26:90-98. 1979. (Pubitemid 10248636)
42. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538. 1970.
43. Witter, R. L., J. M. Sharma, and A. M. Fadly. Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens. Avian Dis. 24:210-232. 1980.